Recruiting NCT05950503
Role of MRI in the Evaluation of Hepatic Metastases of Colorectal Cancer
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Hepatic MRI.
- Who it may be relevant to
- Registry conditions: Colorectal Cancer. Basic parameters: 18 years — 85 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Italy
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Single-center Ambispective Observational Study on the Role of Magnetic Resonance Imaging (MRI) in the Evaluation of Patient Affected by Hepatic Metastases of Carcinoma of the
Overview
This study wants to evaluate the use of MRI in the managemente of mCRC with liver only metastases.
Detailed description
This study wants to evaluate the use of MRI in the managemente of mCRC with liver only metastases.
Interventions
- Radiation Hepatic MRI
The patients will undergo hepatic MRI in pre-established timepoints
Primary outcome measures
- Surgery conversion rates [Time frame: 3 years]
Secondary outcome measures (1)
- Overall survival [Time frame: 3 years]
Eligibility criteria
Inclusion criteria
- Age > 18 years;
- Histological diagnosis of colorectal cancer;
- Presence of liver metastases in the staging exams (chest-abdomen CT with contrast medium or PET-CT with 18-FDG);
- At least one measurable liver lesion according to RECIST 1.1 criteria;
- Adequate organ and marrow function.
Exclusion criteria
- Age < 18 years;
- Inability to undergo MRI;
- Major contraindications to liver surgery;
- No written informed consent.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
Italy · 1 center
- Policlinico Agostino Gemelli — Roma
Identifiers
NCT: NCT05950503 · 5829